TGFB1 and neoplasm: Johnson et al. (2021) engineered CAR-T cells to co-express an immunostimulatory RNA molecule and found that this impaired MDSC development, decreased TGFβ production by myeloid cells, and led to enhanced CAR-T cell proliferation and tumor control in mice with solid tumors [197].